Patents Assigned to COMET THERAPEUTICS, INC. - Justia Patents Search

Patents Assigned to COMET THERAPEUTICS, INC.

Phosphopantetheine compounds alone or in combination with HMG-CoA reductase inhibitors for lowering serum cholesterol and serum triglicerides

Patent number: 10624908

Abstract: The invention relates to the use of phosphopantetheine compounds alone and in combination with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Preferred medical uses relate to the treatment or prevention of dyslipidemia.

Type: Grant

Filed: December 23, 2015

Date of Patent: April 21, 2020

Assignees: COMET THERAPEUTICS, INC., RIJKSUNIVERSITEIT GRONINGEN, ACADEMISCH ZIEKENHUIS GRONINGEN

Inventors: Gregor Kosec, Stefan Fujs, Hrvoje Petkovic, Oda Cornelia Maria Sibon, Balaji Srinivasan